Back ground: Atherosclerosis is a disease of large and medium-sized muscular arteries and is a progressive disease characterized by the accumulation of lipids and fibrous elements in the large arteries.
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Introduction :
Atherosclerosis is a multifactorial, multistep disease that involves chronic inflammation at every stage, from initiation to progression and, (1) eventually, plaque rupture. Cardiovascular disease (CVD) is the leading cause of death and disability in developed nations and is increasing rapidly in the developing word. (1, 2) Endothelial dysfunction is the initial step that allows diffusion of lipids and inflammatory cells (ie, monocytes, T lymphocytes) into the endothelial and subendothelial spaces. Secretion of cytokines and growth factors promotes intimal migration; SMC proliferation; and accumulation of collagen matrix, monocytes, and other white blood cells, forming an atheroma. (3) Incretin hormones: The role of the gastrointestinal tract in regulating the secretion of insulin is demonstrated by the observation that insulin secretion is substantially increased in response to oral glucose, compared to intravenous glucose administration. This difference is known as the incretin effect these peptides are secreted from endocrine cells (L-cells) in the gastrointestinal tract, and are released in response to ingestion of food. The two main incretin hormones are glucagon-like peptide-1 (GLP-1) and glucosedependent insulinotropic polypeptide (GIP), DDP-IV is proteolytic enzyme widely expressed in many tissues, including the capillary bed of the gut mucosa responsible for rapid inactivation of (GLP-1). (4) Incretin mimetics and DPP-4 inhibitors address the need to act on the underlying disease rather than on its symptoms. They enhance glucosedependent insulin secretion by pancreatic beta cells, and consequently there is little risk of hypoglycemia. They also suppress elevated glucagon secretion and increase satiety. It has been hypothesized that they may restore beta-cell sensitivity to glucose, which could mean that they may be able to delay the onset of type 2 diabetes, slow its progression, and reduce its cardiovascular and metabolic complications (5) vildagliptin is a potent, reversible, competitive inhibitor of DPP-4, with high selectivity for DPP-4 over other peptidase enzymes (6) vildagliptin inhibits the activation of GLP-1and GIP by Dpp-4allowing GLP-1and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancrease Materials and methods Animals.18 local domestic male rabbits were included in this study from animal house of the faculty of medicine /kufa university . The animals were housed in cages and kept at room temperature and then randomly divided into three groups (6rabbits in each group): Group I rabbits fed normal chow (oxiod) diet for 12 weeks. Group II rabbits fed 1% cholesterol enriched diet for 12 weeks. Group III rabbits fed with cholesterol enriched diet for 6 weeks, and then continued on cholesterol enriched diet and treated with vildaglipin 50mg/kg/day orally for the next 6 weeks. Blood samples were collected at the start of the study, at 6weeks of the study and then at the end of treatment course for measurement of Serum lipids profile [(TC), (TG), (HDL)] , hsCRP, TNFα at the end of the study the aorta were removed for measurement of aortic MDA ,glutathione and Aortic intima-media thickness and sectioning for histopathology. Vildagliptin:it was used in dose of 50mg/kg ,50 mg galvus tablet supplied by (Novartis)was suspended in distilled water and the dose was given according to body weight ,once dialy through stomach tube.
Preparation of samples
From each rabbit about 3 ml of blood was collected from the central ear artery without use of heparin after an overnight fasting. The blood sampling was done firstly at the start of the study i.e. at zero time and after 6 weeks of the induction period, and then at end of treatment course (12week). The blood samples were allowed to clot at 37 C° and centrifuged at 3000 rpm for 15 min. Sera were taken, and analyzed for determination of serum total cholesterol, triglycerides, HDL-C , hs.C-reactive protein and TNF-α. Tissue preparation for oxidative stress measurement 20% homogenates of tissues were prepared in phosphate buffer at pH 7.5 containing 1 mmol/l Na 2 EDTA. The homogenates were centrifuged at 20,000 ×g at 4 C for 30 min and the supernatants were used for biochemical measurements of GSH &MDA level Histopathological procedure Autopsy of aortic (abdominal and thoracic aorta) sectioning were done at the end of the study (after 12 weeks), the histopathology is used to confirm the anti-atherogenic effect of sitagliptin in comparison with the control groups (normal control and induced untreated control). The sections were examined by microscope under magnification power of (×4, ×10 and ×40) then the histological changes were determined according to the American Heart Association classification of atherosclerosis (7) which divides atherosclerotic lesions into six types as follows: 
Discussion
In this study we demonstrate that high atherogenic diet cause significant increment in lipid parameter 
